JP5150909B2 - 食道癌を診断する方法 - Google Patents

食道癌を診断する方法 Download PDF

Info

Publication number
JP5150909B2
JP5150909B2 JP2008504285A JP2008504285A JP5150909B2 JP 5150909 B2 JP5150909 B2 JP 5150909B2 JP 2008504285 A JP2008504285 A JP 2008504285A JP 2008504285 A JP2008504285 A JP 2008504285A JP 5150909 B2 JP5150909 B2 JP 5150909B2
Authority
JP
Japan
Prior art keywords
dkk1
expression
gene
cancer
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008504285A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009502116A5 (https=
JP2009502116A (ja
Inventor
祐輔 中村
弥太郎 醍醐
修一 中鶴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of JP2009502116A publication Critical patent/JP2009502116A/ja
Publication of JP2009502116A5 publication Critical patent/JP2009502116A5/ja
Application granted granted Critical
Publication of JP5150909B2 publication Critical patent/JP5150909B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2008504285A 2005-07-27 2006-07-26 食道癌を診断する方法 Expired - Fee Related JP5150909B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70326305P 2005-07-27 2005-07-27
US60/703,263 2005-07-27
PCT/JP2006/315342 WO2007013671A2 (en) 2005-07-27 2006-07-26 Method of diagnosing esophageal cancer

Publications (3)

Publication Number Publication Date
JP2009502116A JP2009502116A (ja) 2009-01-29
JP2009502116A5 JP2009502116A5 (https=) 2009-09-10
JP5150909B2 true JP5150909B2 (ja) 2013-02-27

Family

ID=37311591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008504285A Expired - Fee Related JP5150909B2 (ja) 2005-07-27 2006-07-26 食道癌を診断する方法

Country Status (6)

Country Link
US (2) US8053183B2 (https=)
EP (5) EP2311985A1 (https=)
JP (1) JP5150909B2 (https=)
CN (1) CN101273144B (https=)
ES (1) ES2379805T3 (https=)
WO (1) WO2007013671A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8429342B2 (en) 2003-05-22 2013-04-23 Hitachi, Ltd. Drive apparatus and method for controlling the same

Families Citing this family (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
US8916530B2 (en) * 2005-11-18 2014-12-23 Gradalis, Inc. Individualized cancer therapy
US8603991B2 (en) 2005-11-18 2013-12-10 Gradalis, Inc. Individualized cancer therapy
RU2008141912A (ru) * 2006-03-23 2010-04-27 Новартис АГ (CH) Противоопухолевые лекарства на основе антител к клеточным антигенам
JP5339291B2 (ja) 2006-08-10 2013-11-13 オンコセラピー・サイエンス株式会社 乳癌に関連する遺伝子およびポリペプチド
US7811778B2 (en) * 2006-09-06 2010-10-12 Vanderbilt University Methods of screening for gastrointestinal cancer
WO2008082730A2 (en) * 2006-09-19 2008-07-10 Novartis Ag Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors
US8906874B2 (en) 2006-11-09 2014-12-09 Gradalis, Inc. Bi-functional shRNA targeting Stathmin 1 and uses thereof
US8758998B2 (en) 2006-11-09 2014-06-24 Gradalis, Inc. Construction of bifunctional short hairpin RNA
US8252526B2 (en) 2006-11-09 2012-08-28 Gradalis, Inc. ShRNA molecules and methods of use thereof
EP2102360A2 (en) * 2006-12-13 2009-09-23 Oncotherapy Science, Inc. Ttk as tumor marker and therapeutic target for lung cancer
EP2130048B1 (en) * 2007-03-23 2012-04-18 F. Hoffmann-La Roche AG Apex as a marker for lung cancer
WO2008127199A1 (en) * 2007-04-13 2008-10-23 Agency For Science, Technology And Research Methods of controlling tumorigenesis and diagnosing the risk thereof
TW200908998A (en) * 2007-06-27 2009-03-01 Oncotherapy Science Inc Compositions and methods of treating cancer
US8569244B2 (en) 2007-08-20 2013-10-29 Oncotherapy Science, Inc. FOXM1 peptide and medicinal agent comprising the same
PT2186889E (pt) * 2007-08-20 2015-06-17 Oncotherapy Science Inc Péptido cdca1 e agente farmacêutico que o compreende
WO2009028581A1 (en) * 2007-08-24 2009-03-05 Oncotherapy Science, Inc. Cancer-related genes, cdca5, epha7, stk31 and wdhd1
TW200920406A (en) * 2007-08-24 2009-05-16 Oncotherapy Science Inc EBI3, DLX5, NPTX1 and CDKN3 for target genes of lung cancer therapy and diagnosis
WO2009028158A1 (en) 2007-08-24 2009-03-05 Oncotherapy Science, Inc. Dkk1 oncogene as therapeutic target for cancer and a diagnosing marker
CN101855346A (zh) * 2007-08-24 2010-10-06 肿瘤疗法科学股份有限公司 Pkib和naaladl2用作前列腺癌治疗和诊断的靶基因
KR20160096213A (ko) * 2007-09-11 2016-08-12 캔서 프리벤션 앤 큐어, 리미티드 인간 폐조직 병변의 지표가 되는 인간 혈청 내 단백질의 동정
US8541183B2 (en) 2007-09-11 2013-09-24 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
US20100256610A1 (en) * 2007-10-25 2010-10-07 Basil Rigas Apparatus and method of detection and localized treatment of abnormal conditions
WO2009131366A2 (ko) * 2008-04-21 2009-10-29 한국생명공학연구원 위암 또는 대장암 진단 마커 및 치료제로서의 ｃdca5
TW201000119A (en) * 2008-06-10 2010-01-01 Oncotherapy Science Inc MYBL2 epitope peptides and vaccines containing the same
TW201000115A (en) * 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
EP2321410A4 (en) * 2008-07-16 2011-09-14 Oncotherapy Science Inc ECT2 ONCOGEN AS A THERAPEUTIC TARGET MOLECULE AND PROGNOSTIC INDICATOR FOR LUNG AND CANCER CANCER
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
EP2334789A1 (en) * 2008-08-27 2011-06-22 Oncotherapy Science, Inc. Breast cancer related gene rqcd1
WO2010023854A1 (en) * 2008-08-27 2010-03-04 Oncotherapy Science, Inc. Cancer related gene, lgn/gpsm2
BRPI0917350A2 (pt) * 2008-08-28 2015-08-11 Oncotherapy Science Inc Oip5 como um gene alvo para terapia e diagnose de câncer
EP2329040B1 (en) * 2008-09-22 2017-10-11 ADVPharma, Inc. Molecular markers for lung and colorectal carcinomas
JP5403534B2 (ja) * 2008-10-29 2014-01-29 インフォコム株式会社 食道癌の予後予測のための情報を提供する方法
TWI469791B (zh) 2009-02-18 2015-01-21 Oncotherapy Science Inc Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
CN108181457B (zh) 2009-03-12 2021-03-30 癌症预防和治疗有限公司 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒
TW201100090A (en) * 2009-04-01 2011-01-01 Oncotherapy Science Inc C6orf167 peptides and vaccines containing the same
TW201102081A (en) 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
TWI507204B (zh) * 2009-05-26 2015-11-11 Oncotherapy Science Inc Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
WO2010151731A1 (en) * 2009-06-26 2010-12-29 University Of Utah Research Foundation Materials and methods for the identification of drug-resistant cancers and treatment of same
EP2464749A1 (en) * 2009-08-13 2012-06-20 Oncotherapy Science, Inc. Cdc45l as tumor marker and therapeutic target for cancer
JP2013013327A (ja) * 2009-10-29 2013-01-24 Actgen Inc Ｍａｎｓｃ１蛋白質に結合し、抗癌活性を有する抗体
KR101142131B1 (ko) * 2009-11-05 2012-05-11 (주)지노믹트리 장암 진단을 위한 장암 특이적 메틸화 마커 유전자의 메틸화 검출방법
US10428388B2 (en) 2009-11-05 2019-10-01 Genomictree, Inc. Method for detecting the methylation of colorectal-cancer-specific methylation marker genes for colorectal cancer diagnosis
SG181880A1 (en) 2009-12-23 2012-07-30 Gradalis Inc Furin-knockdown and gm-csf-augmented (fang) cancer vaccine
TWI538685B (zh) * 2010-04-02 2016-06-21 腫瘤療法 科學股份有限公司 Ｅｃｔ２胜肽及含此胜肽之疫苗
US20110269171A1 (en) * 2010-04-19 2011-11-03 Shapiro Virginia M Methods and materials for using nkap polypeptide expression levels or patterns to detect or assess cancer
EP2594274B1 (en) 2010-06-04 2015-09-23 Kao Corporation Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
WO2012023259A1 (en) * 2010-08-19 2012-02-23 Oncotherapy Science, Inc. C6orf167 as a target gene for cancer therapy and diagnosis
WO2012023284A1 (en) * 2010-08-20 2012-02-23 Oncotherapy Science, Inc. Lhx4 as a target gene for cancer therapy and diagnosis
WO2012103787A1 (en) * 2011-02-01 2012-08-09 The University Of Hongkong Use of anti-dkk1 monoclonal antibody for treatment of liver cancer
JP6064231B2 (ja) * 2011-06-03 2017-01-25 オンコセラピー・サイエンス株式会社 がん治療および診断のための標的遺伝子としてのｓｕｖ３９ｈ２
CN103765220B (zh) * 2011-08-29 2016-02-17 东丽株式会社 大肠癌或食道癌的检测用标志物和检查方法
EP2872532A4 (en) 2012-07-10 2016-04-13 Oncotherapy Science Inc CDCA1-EPITOPPEPTIDES FOR TH1 CELLS AND VACCINES THEREWITH
WO2014011742A1 (en) * 2012-07-11 2014-01-16 University Of Vermont And State Agricultural College Method and composition for metabolic regulation
HK1212767A1 (zh) * 2012-09-12 2016-06-17 Berg Llc 標誌物用於識別心臟毒性劑的用途
TWI643867B (zh) 2013-05-24 2018-12-11 日商腫瘤療法 科學股份有限公司 對於ｔｈ１細胞之ｉｍｐ－３抗原決定位胜肽及含此之疫苗
WO2014208156A1 (ja) * 2013-06-28 2014-12-31 栄研化学株式会社 新規肺癌マーカー（liph）
CN110280123A (zh) * 2013-09-16 2019-09-27 恩弗里德系统公司 用于从室内空气中过滤甲醛的方法和系统
GB201316783D0 (en) * 2013-09-20 2013-11-06 Lordan Jeffrey Cancer biomarkers and diagnostics
US20160313334A1 (en) * 2013-12-31 2016-10-27 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods for the detection of esophageal adenocarcinoma
CN104034902B (zh) * 2014-05-09 2015-11-25 赤峰学院 利用4个蛋白联合预测食道癌患者预后的试剂盒
EP3981416B1 (en) 2014-08-04 2024-03-20 OncoTherapy Science, Inc. Koc1-derived peptide and vaccine including same
JP6700512B2 (ja) 2014-08-04 2020-05-27 オンコセラピー・サイエンス株式会社 Ｃｄｃａ１由来ペプチドおよびそれを含むワクチン
CN104263722A (zh) * 2014-08-06 2015-01-07 温州医科大学附属第一医院 用于人类dermokine基因亚型mRNA表达量检测的扩增引物及其试剂盒
WO2016047688A1 (ja) * 2014-09-24 2016-03-31 国立研究開発法人国立がん研究センター 扁平上皮がんに対する化学放射線療法の有効性を評価するための方法
CN104360062B (zh) * 2014-11-28 2017-03-08 山东新创生物科技有限公司 肽基精氨酸脱亚胺酶1在制备肿瘤临床诊断试剂中的应用
CN105588941A (zh) * 2015-02-28 2016-05-18 苏州飞康生物医药有限公司 一种检测肿瘤标志物dkk1 浓度的酶联免疫试剂盒
CN104749381B (zh) * 2015-03-30 2017-03-15 石河子大学 组装抑制蛋白pfn2在制备食管癌诊断试剂中的用途
CR20230563A (es) 2015-07-06 2024-01-22 Immatics Biotechnologies Gmbh NUEVOS PÉPTIDOS Y COMBINACIÓN DE PÉPTIDOS PARA USAR EN INMUNOTERAPIA CONTRA EL CÁNCER ESOFÁGICO Y OTROS CÁNCERES (Divisional Exp. 2017-0579)
BR112018006005A2 (pt) 2015-09-29 2018-10-30 Oncotherapy Science Inc composto bicíclico e uso do mesmo para inibição de suv39h2
DK3356558T3 (da) * 2015-09-30 2022-04-25 Immunexpress Pty Ltd Sirs patogenbiomarkører og anvendelser deraf
BR112018005581A2 (pt) 2015-10-08 2018-10-16 Oncotherapy Science, Inc. peptídeo derivado de foxm1 e vacina incluindo o mesmo
CN105506112A (zh) * 2015-12-31 2016-04-20 济宁医学院 Prss8检测试剂在制备食管炎和胃炎诊断试剂盒中的应用
GB201602210D0 (en) * 2016-02-08 2016-03-23 Ucl Business Plc Detection of cancer
EP3415637B1 (en) * 2016-02-10 2023-05-10 Fukushima Medical University Method for differentiating contraction of esophageal basaloid carcinoma
CN105671158B (zh) * 2016-02-29 2019-01-18 北京泱深生物信息技术有限公司 Fam63b基因在制备诊治子宫肌瘤的产品中的用途
CN107287174B (zh) * 2016-04-12 2020-08-25 中国科学技术大学 肝癌标志物oxct1及其在肝癌诊断、治疗以及预后中的应用
KR102047502B1 (ko) * 2016-06-20 2019-11-22 셀라이온바이오메드 주식회사 포타슘 채널 단백질을 이용한 암 진단용 조성물
WO2017223216A1 (en) * 2016-06-21 2017-12-28 The Wistar Institute Of Anatomy And Biology Compositions and methods for diagnosing lung cancers using gene expression profiles
EP3516390A1 (en) * 2016-09-23 2019-07-31 Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis Manipulation of immune activity by modulation of expression
CN110139875B (zh) * 2016-09-30 2023-03-03 武汉华大吉诺因生物科技有限公司 Col14a1衍生的肿瘤抗原多肽及其应用
CN106520925A (zh) * 2016-10-14 2017-03-22 浙江大学 一种用于检测食道癌的引物组及检测方法
CN106676183A (zh) * 2017-02-09 2017-05-17 复旦大学 Zfhx4作为食管癌预后诊断的生物标志物
CN110709936A (zh) 2017-04-04 2020-01-17 肺癌蛋白质组学有限责任公司 用于早期肺癌预后的基于血浆的蛋白质概况分析
EP3682034A1 (en) * 2017-09-13 2020-07-22 Alexera AB Methods for identifying therapeutic agents which interact with stk24
US11028146B2 (en) * 2017-09-22 2021-06-08 Modern Meadow, Inc. Recombinant yeast strains
US11768205B2 (en) 2017-11-06 2023-09-26 Mayo Foundation For Medical Education And Research Methods and materials for identifying and treating cancers having elevated levels of phosphorylated ubiquitin
CA3085464A1 (en) 2017-12-19 2019-06-27 The Wistar Institute Of Anatomy And Biology Compositions and methods for diagnosing lung cancers using gene expression profiles
KR102194644B1 (ko) * 2018-04-26 2020-12-24 주식회사 굳티셀 신규한 융합 단백질 및 이를 포함하는 암의 예방 또는 치료용 약학적 조성물
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
EP3847282A4 (en) * 2018-09-06 2022-06-01 The Council of the Queensland Institute of Medical Research BIOMARKERS FOR CANCER THERAPY
CN109266743B (zh) * 2018-09-13 2019-09-10 中国科学院苏州生物医学工程技术研究所 一种癌症标志物及其用途
CN109342729B (zh) * 2018-10-30 2021-06-25 深圳格道糖生物技术有限公司 特定凝集素组合在基于唾液糖型鉴别食管癌方面的应用
CN109633142B (zh) * 2018-12-22 2021-08-27 中国人民解放军第四军医大学 一种急性髓细胞性白血病诊断模型的建立方法及其应用
JP7317379B2 (ja) * 2019-01-04 2023-07-31 国立大学法人京都大学 潰瘍性大腸炎及び原発性硬化性胆管炎の検査方法
CN109652544A (zh) * 2019-01-11 2019-04-19 山西医科大学 锌指蛋白750基因在制备食管鳞癌诊断试剂中的用途
WO2020190104A1 (ko) * 2019-03-20 2020-09-24 주식회사 굳티셀 뇌신경계 질환의 예방 또는 치료용 조성물
CN109852697A (zh) * 2019-03-28 2019-06-07 中国科学院上海生命科学研究院 腺鳞癌诊断的分子靶点及其应用
WO2020213084A1 (en) * 2019-04-17 2020-10-22 Keio University Anti aqp3 monoclonal antibody specifically binding to extracellular domain of aquaporin 3 (aqp3) and use thereof
CN110358833B (zh) * 2019-07-11 2021-10-15 江苏医药职业学院 检测Tudor结构域蛋白2表达水平的试剂的应用和试剂盒
CN112444627B (zh) * 2019-09-05 2022-03-29 四川大学华西医院 一种高危胸痛筛查试剂盒
CN110609136B (zh) * 2019-09-18 2022-08-09 中国人民解放军陆军军医大学第一附属医院 Zyx斑联蛋白在恶性脑胶质母细胞瘤诊断及治疗中的应用
CN110836968A (zh) * 2019-12-09 2020-02-25 四川大学华西医院 C9orf45自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
CN112980914A (zh) * 2019-12-12 2021-06-18 中国科学院大连化学物理研究所 Gfpt1基因作为靶点在筛选抗肿瘤药物中的应用
CN113101368B (zh) * 2020-01-13 2022-10-21 中国医学科学院肿瘤医院 Slc7a8在食管鳞癌辅助诊断、癌前预警和靶向治疗中的应用
CN113138278A (zh) * 2020-01-19 2021-07-20 中国医学科学院肿瘤医院 S100a7蛋白作为标志物在食管鳞癌辅助诊断和预后判断中的应用
EP4117640A4 (en) * 2020-03-09 2024-03-27 The Regents of the University of California FEM1B PROTEIN BINDING AGENTS AND RELATED USES
CN111505292A (zh) * 2020-04-03 2020-08-07 青岛大学附属医院 基于pck1调节的脂质代谢作为癌症治疗、诊断和预后预测之靶标的应用
CN111505296B (zh) * 2020-05-06 2020-12-22 郑州大学第一附属医院 食管癌相关抗体蛋白组合在胶体金试纸条中的应用
CN111551545B (zh) * 2020-05-25 2020-11-06 郑州大学第一附属医院 一种用于食管癌高危人群早期筛查的液体活检elisa试剂盒
EP4158356B1 (en) * 2020-06-01 2024-04-10 Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea In vitro methods for the prognosis of amyotrophic lateral sclerosis
CN112433052A (zh) * 2020-12-01 2021-03-02 中国医学科学院肿瘤医院 肺腺癌预后的预测方法
CN114672553B (zh) * 2020-12-24 2024-11-01 中国医学科学院肿瘤医院 Krt15在食管癌辅助诊断和靶向治疗中的用途
CN112843234B (zh) * 2021-01-20 2022-09-06 四川大学华西第二医院 一种调控生物机体内gdp-甘露糖的浓度的装置
CN113066577B (zh) * 2021-03-02 2024-01-26 四川省肿瘤医院 一种基于凝血指数的食管鳞癌生存率预测系统
CN113355418B (zh) * 2021-06-15 2022-11-08 上海长征医院 用于骨肉瘤分型和评估骨肉瘤预后的基因及其应用
CN115612734B (zh) * 2021-07-14 2025-11-18 郑州大学 人食管鳞状细胞癌的分子标记物组及其应用
CN113789331B (zh) * 2021-07-28 2023-05-23 温州医科大学 一种识别肿瘤靶蛋白jup的方法及核酸适体pq-6与应用
CN114146178A (zh) * 2021-10-26 2022-03-08 兰州大学第二医院 Pycr1基因作为靶标在制备食管癌产品中的用途及相关产品
CN114134229A (zh) * 2021-10-28 2022-03-04 贵州百镜生物科技有限公司 结直肠癌和/或肠息肉诊断标志物、试剂盒、方法及应用
EP4427050A4 (en) * 2021-11-03 2025-10-29 Toreador Therapeutics Inc METHODS AND SYSTEMS FOR SUPER-RESOLUTION STUDYING OF THERAPIES
CN114167059B (zh) * 2021-11-03 2023-07-14 郑州大学 一种用于食管鳞癌诊断的生物标志物及检测试剂盒
CN114195865A (zh) * 2021-12-23 2022-03-18 上海市同仁医院 一种sh3bgrl3衍生多肽及其应用
CN114668846B (zh) * 2022-04-08 2023-05-02 南阳理工学院 去泛素化酶usp45在制备治疗食管癌药物中的应用
CN114592007B (zh) * 2022-04-29 2023-10-27 昆明理工大学 Far1基因的新用途
CN115417920B (zh) * 2022-06-21 2025-10-31 泰州市人民医院 靶向dhx38多肽构建及其抗肝细胞癌干细胞活性应用
CN115253682B (zh) * 2022-07-29 2024-02-02 烟台至公生物医药科技有限公司 一种膀胱癌细胞捕获装置及捕获方法
CN115381953B (zh) * 2022-10-14 2023-08-11 天津医科大学总医院 Zip1在抑制瑞芬太尼诱发的痛觉过敏中的应用
CN116794309A (zh) * 2022-11-07 2023-09-22 汕头大学医学院 一种可作为肿瘤诊断和预后分析标志物的fascin乙酰化修饰及其检测试剂和应用
CN115993455A (zh) * 2022-12-29 2023-04-21 南京医科大学康达学院 Rna结合蛋白nova2作为非小细胞肺癌转移标志物的应用
CN116381237B (zh) * 2023-02-28 2024-06-11 杭州凯保罗生物科技有限公司 一种甲状腺癌早期预测系统及其应用
CN117210561A (zh) * 2023-05-09 2023-12-12 山东第一医科大学第一附属医院(山东省千佛山医院) Rnf106在食管鳞癌检测、治疗和预后靶点及应用
CN117607434A (zh) * 2023-10-18 2024-02-27 石河子大学 溶质载体蛋白slc43a2作为标志物在制备诊断和/或预后评估食管癌的产品中的应用
CN117451985B (zh) * 2023-10-24 2024-05-03 首都医科大学附属北京朝阳医院 MCM7蛋白的Thr456和Thr601位点的应用
CN117604111B (zh) * 2024-01-23 2024-04-12 杭州华得森生物技术有限公司 用于小细胞肺癌诊断和预后判断的生物标志物及其应用
CN117647645B (zh) * 2024-01-29 2024-04-12 中国人民解放军总医院第一医学中心 Lbp、atf6、m-csfr联用在制备诊断自身免疫性肝病产品中的应用及试剂盒

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
AU664172B2 (en) 1991-02-21 1995-11-09 Smithkline Beecham Corporation Treatment of esophageal cancer
US7057017B2 (en) * 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
JPH11187884A (ja) * 1997-12-26 1999-07-13 Hsp Kenkyusho:Kk 熱ショック転写因子結合蛋白質
CN1223677C (zh) 1999-08-10 2005-10-19 中国医学科学院肿瘤医院肿瘤研究所 一种食管癌相关基因
CN1150317C (zh) * 1999-08-10 2004-05-19 中国医学科学院肿瘤医院肿瘤研究所 一种食管癌相关新基因
CA2405431A1 (en) * 2000-03-31 2001-10-11 Gene Logic, Inc. Gene expression profiles in esophageal tissue
EP1332153A4 (en) 2000-10-12 2006-01-11 Exelixis Inc HUMAN ECT2 AND METHOD OF USE THEREOF
JP2003226646A (ja) * 2002-01-30 2003-08-12 Kaken Pharmaceut Co Ltd インターフェロン遺伝子包埋多重膜リポソームを用いる食道癌治療用抗癌剤
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
AU2003295600A1 (en) * 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna
JP2007508020A (ja) * 2003-09-30 2007-04-05 カイロン コーポレイション ヒトｄｋｋｌ１の新規スプライス改変体
US7700573B2 (en) 2004-03-23 2010-04-20 Oncotherapy Science, Inc. Method for diagnosing non-small lung cancer
US8065093B2 (en) * 2004-10-06 2011-11-22 Agency For Science, Technology, And Research Methods, systems, and compositions for classification, prognosis, and diagnosis of cancers
JP2006217844A (ja) * 2005-02-09 2006-08-24 Univ Of Tokyo Ｄｋｋ１の遺伝子、蛋白質及び抗体を用いた癌の診断・モニター方法及び治療方法
CA2607133A1 (en) * 2005-05-02 2006-11-09 Toray Industries, Inc. Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
CN1963511B (zh) 2005-11-11 2014-09-24 上海市肿瘤研究所 Dkk-1蛋白在癌症诊断中的应用
WO2007104181A1 (en) 2006-03-13 2007-09-20 Shanghai Cancer Institute Uses of dkk-1 protein in diagnosis of cancers
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
BRPI0917350A2 (pt) 2008-08-28 2015-08-11 Oncotherapy Science Inc Oip5 como um gene alvo para terapia e diagnose de câncer
TW201100090A (en) 2009-04-01 2011-01-01 Oncotherapy Science Inc C6orf167 peptides and vaccines containing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8429342B2 (en) 2003-05-22 2013-04-23 Hitachi, Ltd. Drive apparatus and method for controlling the same

Also Published As

Publication number Publication date
ES2379805T3 (es) 2012-05-03
EP2298933A1 (en) 2011-03-23
US20120021946A1 (en) 2012-01-26
EP2311986A1 (en) 2011-04-20
WO2007013671A3 (en) 2007-08-30
CN101273144B (zh) 2011-12-28
EP2295602A1 (en) 2011-03-16
EP2311986B1 (en) 2015-04-15
US8053183B2 (en) 2011-11-08
US8771963B2 (en) 2014-07-08
EP2295602B1 (en) 2012-07-11
JP2009502116A (ja) 2009-01-29
WO2007013671A2 (en) 2007-02-01
EP2311985A1 (en) 2011-04-20
CN101273144A (zh) 2008-09-24
US20090208514A1 (en) 2009-08-20
EP1907582B1 (en) 2012-01-04
EP1907582A2 (en) 2008-04-09

Similar Documents

Publication Publication Date Title
JP5150909B2 (ja) 食道癌を診断する方法
JP4620670B2 (ja) 乳癌を診断する方法
WO2007013665A2 (en) Method of diagnosing small cell lung cancer
US8029981B2 (en) Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma
JP2006500948A (ja) 膵臓癌を診断する方法
US20130137584A1 (en) Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignancies
JP2006500946A (ja) 精巣精上皮腫の診断方法
US20100291091A1 (en) Cancer associated gene ly6k
US20130084578A1 (en) Breast cancer related gene znfn3a1
WO2007013575A2 (en) Method for diagnosing and treating renal cell carcinoma
JP2006500950A (ja) 前立腺癌の診断法
WO2008102906A1 (en) Hspc-hrpc transition genes
US10184942B2 (en) Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
KR101657033B1 (ko) V-ATPase subunit V1E1의 단백질 발현 수준을 측정하여 식도암 환자의 생존율과 예후를 예측하는 방법
US20080063640A1 (en) Pin-Prc Transition Genes
US20110070245A1 (en) Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer
WO2010123124A1 (ja) 固形がんの再発および予後因子、およびその臨床利用
US20080199468A1 (en) Method For Diagnosing Colorectal Cancers
US8182997B2 (en) Prostate cancer related gene STYK1

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090724

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120423

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120606

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121005

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121031

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121109

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151214

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5150909

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151214

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees